Skip to content

VELAB: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

VELAB

BE 0440.240.636
NACE 86.910, Medical imaging and medical laboratories
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€783,409
2024 · €943,499-€160,090
Equity
€468,079
2024 · €584,669-€116,591
Cash
€1.0m
2024 · €1.1m-€94,446
Balance sheet total
€1.6m
2024 · €1.6m-€24,860

Largest movements

2024 to 2025
Assets
  • Cash -€94,446

    down €94,446 (-8.5%), from €1.1m to €1.0m

    mainly Contributions, distributions and other (-€900,000) and Receivables within one year (-€42,814)

  • Receivables within one year +€42,814

    up €42,814 (+9.7%), from €441,980 to €484,794

    of which Other amounts receivable: +€62,399

  • Stocks and contracts +€28,467

    up €28,467 (+55.1%), from €51,668 to €80,135

Equity and liabilities
  • Profit (loss) carried forward -€116,591

    down €116,591 (-36.8%), from €316,469 to €199,879

  • Other debts +€51,645

    up €51,645 (+5.9%), from €872,163 to €923,809

  • Trade debts +€40,085

    up €40,085 (+26.7%), from €150,349 to €190,434

Income statement
  • Services and other goods +€98,200

    up €98,200 (+17.4%), from €563,997 to €662,197

  • Turnover -€77,682

    down €77,682 (-3.5%), from €2.2m to €2.1m

  • Taxes -€52,201

    down €52,201 (-16.5%), from €316,801 to €264,600

  • Write-downs +€41,284

    up €41,284 (+64.0%), from -€64,473 to -€23,189

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €943,499
Turnover -€77,682
Other operating income -€11,793
Goods and materials -€4,366
Services and other goods -€98,200
Write-downs -€41,284
Other operating charges +€16,111
Financial income +€12,357
Financial charges -€7,434
Taxes +€52,201
Result 2025 €783,409

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€805,554
Investment €0
Financing -€900,000
Cash 2024 €1.1m
Net result for the year +€783,409
Depreciation +€512
Stocks and contracts -€28,467
Receivables within one year -€42,814
Deferred charges and accrued income +€1,184
Trade debts +€40,085
Other debts +€51,645
Contributions, distributions and other -€900,000
Cash 2025 €1.0m
Every line side by side 51 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,607,182 €1,582,322 -€24,860 -1.5%
Fixed assets 21/28 €808 €296 -€512 -63.4%
Intangible fixed assets 21 €808 €296 -€512 -63.4%
Current assets 29/58 €1,606,374 €1,582,026 -€24,348 -1.5%
Stocks and contracts in progress 3 €51,668 €80,135 +€28,467 +55.1%
Stocks 30/36 €51,668 €80,135 +€28,467 +55.1%
Raw materials and consumables 30/31 €51,668 €80,135 +€28,467 +55.1%
Amounts receivable within one year 40/41 €441,980 €484,794 +€42,814 +9.7%
Trade receivables 40 €432,851 €413,266 -€19,585 -4.5%
Other amounts receivable 41 €9,129 €71,528 +€62,399 +683.5%
Cash at bank and in hand 54/58 €1,111,369 €1,016,923 -€94,446 -8.5%
Deferred charges and accrued income 490/1 €1,357 €173 -€1,184 -87.2%
Total equity and liabilities 10/49 €1,607,182 €1,582,322 -€24,860 -1.5%
Equity 10/15 €584,669 €468,079 -€116,591 -19.9%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €206,200 €206,200 = 0.0%
Non-distributable reserves 130/1 €6,200 €6,200 = 0.0%
Legal reserve 130 €6,200 €6,200 = 0.0%
Distributable reserves 133 €200,000 €200,000 = 0.0%
Profit (loss) carried forward 14 €316,469 €199,879 -€116,591 -36.8%
Amounts payable 17/49 €1,022,513 €1,114,243 +€91,730 +9.0%
Amounts payable within one year 42/48 €1,022,513 €1,114,243 +€91,730 +9.0%
Trade debts 44 €150,349 €190,434 +€40,085 +26.7%
Suppliers 440/4 €150,349 €190,434 +€40,085 +26.7%
Other amounts payable 47/48 €872,163 €923,809 +€51,645 +5.9%
Operating income 70/76A €2,277,928 €2,188,453 -€89,476 -3.9%
Turnover 70 €2,221,898 €2,144,216 -€77,682 -3.5%
Other operating income 74 €56,030 €44,237 -€11,793 -21.0%
Operating charges 60/66A €1,038,953 €1,166,693 +€127,739 +12.3%
Goods for resale, raw materials and consumables 60 €484,527 €488,894 +€4,366 +0.9%
Purchases 600/8 €498,083 €517,360 +€19,278 +3.9%
Change in stocks: decrease (increase) 609 -€13,556 -€28,467 -€14,911 -110.0%
Services and other goods 61 €563,997 €662,197 +€98,200 +17.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €512 €512 = 0.0%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 -€64,473 -€23,189 +€41,284 +64.0%
Other operating charges 640/8 €54,390 €38,278 -€16,111 -29.6%
Operating profit (loss) 9901 €1,238,975 €1,021,760 -€217,215 -17.5%
Financial income 75/76B €23,399 €35,757 +€12,357 +52.8%
Recurring financial income 75 €23,399 €35,757 +€12,357 +52.8%
Income from current assets 751 €3,100 €6,663 +€3,563 +114.9%
Other financial income 752/9 €20,299 €29,094 +€8,795 +43.3%
Financial charges 65/66B €2,074 €9,508 +€7,434 +358.5%
Recurring financial charges 65 €2,074 €9,508 +€7,434 +358.5%
Other financial charges 652/9 €2,074 €9,508 +€7,434 +358.5%
Profit (loss) for the period before taxes 9903 €1,260,300 €1,048,009 -€212,291 -16.8%
Income taxes 67/77 €316,801 €264,600 -€52,201 -16.5%
Taxes 670/3 €316,801 €264,600 -€52,201 -16.5%
Profit (loss) for the period 9904 €943,499 €783,409 -€160,090 -17.0%
Profit (loss) for the period to be appropriated 9905 €943,499 €783,409 -€160,090 -17.0%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.